Table 1.
Characteristics of study participants
| Parameter (mean ± SD) | Y.O (n = 8) | Y.IV (n = 9) | O.O (n = 8) | P |
|---|---|---|---|---|
| Age (y) | 26 ± 4.4 | 22 ± 1.9 | 69 ± 3.8 | **** |
| Height (m) | 1.80 ± 0.1 | 1.79 ± 0.03 | 1.70 ± 0.1 | * |
| Body mass (kg) | 81.0 ± 11.8 | 78.1 ± 8.8 | 75.8 ± 5.1 | NS |
| BMI (kg m−2) | 25.0 ± 2.8 | 24.4 ± 2.8 | 25.5 ± 1.9 | NS |
| FPG | 4.3 ± 0.9 | 4.4 ± 0.6 | 4.9 ± 1.0 | NS |
Abbreviations: FPG, fasting plasma glucose; NS, not significant; O.O, older group consumed oral EAA; Y.IV, young group given intravenous EAA; Y.O, young group consumed oral EAA.
****
P < 0.0001 O.O vs Y.O and O.O vs Y.IV.
*
P < 0.05 O.O vs Y.O and O.O vs Y.IV.